Corteva Inc. Common Stock vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Corteva Inc. Common Stock trades at $13.82 (market cap $9.64B), while Iovance Biotherapeutics Inc. Common Stock trades at $13.36 (market cap $5.85B). The key difference: Corteva Inc. Common Stock is the larger of the two by market cap, and Corteva Inc. Common Stock pays a 4.98% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Corteva Inc. Common Stock for 0 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| CTVA | IOVA | |
|---|---|---|
Market Cap | $9.64B | $5.85B |
Volume | 41,241,255 | 14,517,176 |
Sector | Basic Materials | Health |
52-Week High | $90.51 | $14.82 |
52-Week Low | $11.92 | $1.81 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $12.15B | $5.78B |
Dividend Yield | 4.98% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Corteva provides seeds, crop protection products, and digital tools for agriculture. Its products are used by farmers to manage crop production and protect yields.
Read more on CTVA →Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →